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Abstract 
Background: This study examined the contribution of various aspects of 
obsessive-compulsive disorder (OCD) on quality of life (QoL) in 102 adults with a 
principal diagnosis of OCD from an archival database. Method: Participants were 
assessed for DSM-IV diagnoses by trained clinicians using the Anxiety Disorders 
Interview Schedule, 4th Edition (ADIS-IV), the Yale-Brown Obsessive-Compulsive Scale 
(Y-BOCS), and an unstructured interview. Further information was attained using the 
Beck Depression Inventory II (BDI-II), the Obsessive Compulsive Inventory Revised 
(OCI-R) and the Medical Outcome Study-36 (MOS-36). Results: Results indicated that 
obsessive-compulsive symptom severity was positively correlated with diminished 
emotional health, social functioning and general health QoL, but not physical health QoL. 
Main effects were found for depression severity, the presence or absence of comorbid 
major depressive disorder and obsessive-compulsive symptom severity and QoL. 
Mediational analyses indicated that interference of obsessive-compulsive symptoms on 
the Y-BOCS mediated the relationship between obsessive-compulsive symptom severity 
and social functioning, emotional health and general health QoL. Mediational analyses 
further revealed that resistance to obsessive-compulsive symptoms on the Y-BOCS was 
a mediator between obsessive-compulsive symptom severity and social functioning QoL. 
Further analyses explained the role of each mediator in the relationship between 
obsessive-compulsive symptom severity and social functioning QoL. Across symptom 
dimensions, persons with OCD had a largely impacted QoL within multiple domains. 
Conclusions: Diminished QoL is common in persons with OCD and is essential in 
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understanding the complete clinical picture of OCD. Results are discussed in terms of 
implications for assessment, treatment and future research.  
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Introduction 
Obsessive-compulsive disorder (OCD) is an anxiety disorder characterized by 
the presence of intrusive thoughts, impulses or images (obsessions) and/or repetitive 
behaviors, rituals or mental acts (compulsions) that cause significant distress or 
interference with daily functioning (American Psychiatric Association, 2000). Clinical 
rates of OCD in adults are estimated between 1-2% (Crino et al., 2005). When left 
untreated, OCD runs a chronic and debilitating course often contributing to interpersonal 
and psychological difficulties throughout adulthood (Norberg, Calamari, Cohen, & 
Riemann, 2008). Comorbidity is common in those with OCD with approximately 70% 
overall comorbidity,  38% comorbidity with generalized anxiety disorder, 31% with major 
depressive disorder, 17% with panic disorder, and lower frequency comorbidity rates 
with PTSD, specific phobias and tic disorders (Storch et al., 2010).   
Several etiological theories have been proposed to explain OCD including 
neurochemistry, neuropsychological, genetic, and cognitive-behavioral theories. The 
neurochemistry theory points to the serotonergic and dopaminergic neurotransmitter 
systems in the pathogenesis of OCD (Markarian et al., 2010). This theory has 
contributed to the development of psychopharmacological treatment protocols for OCD. 
The neuropsychological theory of OCD points to the impairment in fronto-striatal 
executive functioning, including the use of organizational strategies and the organization 
of memories (Aouizerate et al., 2004; Chamberlain, Blackwell, Fineberg, Robbins, & 
Sahakian, 2005; Markarian, et al., 2010). The genetic etiological model focuses on the 
role of genetic features of OCD. To date, no specific gene has been determined to 
explain the disorder, yet family and twin studies reveal that there is a genetic component 
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in the transmission and expression of OCD (Nicolini, Arnold, Nestadt, Lanzagorta, & 
Kennedy, 2009). The cognitive-behavioral etiological theory posits that dysfunctional 
beliefs and misappraisals of intrusive thoughts lead to the development of behaviors that 
attempt to neutralize and diminish obsessions. This theory has led to the development of 
cognitive-behavioral focused treatments for OCD (Doron & Kyrios, 2005).  
The World Health Organization has reported that OCD accounts for 2.5% of 
global years lost due to disability (YLDs) (Ayuso-Mateos, 2000). Given the high rates of 
disability and impairment associated with OCD and comorbid conditions, it is not 
surprising that quality of life (QoL) will be negatively affected by the presence of OCD. 
The construct of QoL is defined by two primary components which include an individual’s 
functional status and an individual’s subjective determination of how their health impacts 
their life (Rapaport, Clary, Fayyad, & Endicott, 2005). Measures of QoL generally 
depend on self-report and therefore indicate an individual’s subjective experience of 
impairment. When investigating QoL it is important to consider the various areas of one’s 
life that may be affected by psychopathological conditions. Quality of life can be looked 
at as one overall blanket measure or can be broken down into various domains. For the 
purposes of the current study, QoL will be defined as having four domains including 
physical health, emotional well-being, social functioning and general QoL. The physical 
health domain will include measures of role limitation due to physical health problems 
(role-physical) and bodily pain. The emotional well-being domain will include measures 
of role limitation due to emotional problems (role-emotional) and mental health. The 
social domain will include a measure of social functioning as it is affected by overall 
physical and mental health. The general QoL domain will include measures of general 
health and vitality (Ware, Snow, Kosinski, & Gandek, 1993). Quality of life across varying 
psychopathological disorders will be discussed next.  
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Quality of life and psychopathology 
Studies have investigated QoL across many psychiatric conditions including 
anxiety disorders, mood disorders, and schizophrenia (Goossens, Hartong, Knoppert-
van der Klein, & van Achterberg, 2008; Masthoff, Trompenaars, Van Heck, Hodiamont, 
& De Vries, 2006; Piccinni et al., 2007; Tomida et al., 2010; Yen et al., 2007). A broad 
range of anxiety and mood disorders are associated with significant QoL impairment 
relative to community norms. Specifically, a meta-analysis addressing QoL impairment 
across psychiatric conditions showed proportions of persons with impaired QoL as 
follows: major depressive disorder (63%), dysthymia (56%), panic disorder (20%), OCD 
(26%), social phobia (21%), and posttraumatic stress disorder (56%) (Rapaport, et al., 
2005). It is important to consider that physical health QoL is generally less impaired in 
adults with anxiety disorders as compared to adults with major depressive disorder or 
posttraumatic stress disorder (Rapaport, et al., 2005). The physical health QoL domain 
is incorporated into overall QoL ratings yielding lower percentages of QoL impairment in 
adults with various anxiety disorders as compared with mood disorders and 
posttraumatic stress disorder. However, results have varied throughout studies 
comparing QoL in OCD to QoL in other psychiatric disorders. Studies have shown QoL 
in those with OCD to be comparable to QoL in adults with schizophrenia (Bobes et al., 
2001), significantly worse than QoL in adults with schizophrenia (Stengler-Wenzke, Kroll, 
Riedel-Heller, Matschinger, & Angermeyer, 2007) and significantly worse than QoL in 
depressed patients (Bobes, et al., 2001). Specific studies of QoL in anxiety disorders, 
affective disorders and schizophrenia are reviewed next. 
Anxiety disorders. Diminished QoL has been well documented across a broad 
range of anxiety disorders including panic disorder, social phobia, generalized anxiety 
disorder, and posttraumatic stress disorder (Barrera & Norton, 2009; Lunney & Schnurr, 
2007; Mendlowicz & Stein, 2000).  Poor QoL in panic disorder is predicted by the 
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severity of panic symptoms, side effects from panic disorder medications, perception of 
low level of social support, comorbid depression severity and an early onset of panic 
disorder (Yen, et al., 2007). Individuals with panic disorder, social phobia and 
generalized anxiety disorder tend to have comparably diminished QoL across disorders 
as compared to non-anxious individuals in the community. Additionally, QoL impairment 
among these three anxiety diagnoses does not differ across specific domains of QoL 
(Barrera & Norton, 2009). Comorbidity of anxiety disorders with depression yields 
significantly greater QoL impairment relative to individuals with an anxiety disorder and 
no depression comorbidity. However, having comorbid anxiety disorders does not 
predict greater impairment relative to the presence of one anxiety disorder alone 
(Barrera & Norton, 2009). Studies addressing QoL outcome in posttraumatic stress 
disorder have found similar results as compared to other anxiety disorders and QoL 
impairment, with numbing symptoms of posttraumatic stress disorder uniquely predicting 
QoL impairment across all QoL domains (Lunney & Schnurr, 2007).  
Affective Disorders. Impaired quality of life in major depression has been well 
documented given that depression is highly comorbid with other psychopathological and 
physiological conditions (Barrera & Norton, 2009; Bobes, et al., 2001; Huppert, Simpson, 
Nissenson, Liebowitz, & Foa, 2009). Longitudinal data show that individuals with major 
depressive disorder (MDD) have significantly impaired quality of well-being over time as 
compared to non-depressed controls. Physical health QoL in persons with MDD is 
significantly lower than physical health QoL in healthy controls as well as persons with 
dysthymic disorder (Goldney, Fisher, Wilson, & Cheok, 2000; Saarijarvi, Salminen, 
Toikka, & Raitasalo, 2002). The severity of MDD symptoms as well as the presence of 
comorbid psychopathological conditions contribute to diminished QoL (Rapaport, et al., 
2005). The relationship between poor QoL and affective disorders has also been 
demonstrated in bipolar I patients, with individuals who have persistent depressive 
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symptoms fairing worse in QoL than those with persistent manic symptoms; both those 
with persistent depressive symptoms and those with persistent manic symptoms have 
significantly more impaired QoL when compared to community norms (Goossens, et al., 
2008; Piccinni, et al., 2007). 
Schizophrenia. Deficits in QoL have been seen in persons with schizophrenia 
and are exhibited by impairments in social functioning, diminished physical health and 
complex emotional issues. In schizophrenia, the presence of depressive and anxiety 
symptoms, low self-esteem and impairment in cognitive functioning contribute to 
diminished QoL (Meijer, Koeter, Sprangers, & Schene, 2009; Tomida, et al., 2010). 
Global functioning and social integration have a less significant role in predicting QoL 
impairment as compared to the presence of depression and anxiety (Meijer, et al., 
2009). Remission from schizophrenia has been associated with improved QoL outcomes 
(Helldin, Kane, Karilampi, Norlander, & Archer, 2008). Next the relationship between 
QoL impairment and OCD symptom severity, number of symptoms, symptom 
dimensions and comorbidity will be discussed. 
Quality of life and obsessive-compulsive disorder 
 Obsessive-compulsive symptom severity and number of symptoms. 
Research addressing the predictors of diminished QoL in OCD is currently characterized 
by mixed results. Studies looking specifically at QoL in OCD have shown that increases 
in OCD symptom severity and number of symptoms correlate with greater QoL 
impairment across all domains (Eisen et al., 2006; Masellis, Rector, & Richter, 2003; 
Moritz et al., 2005). Interestingly, some studies have found that QoL impairment is more 
highly associated with the severity or number of obsessions (Eisen, et al., 2006), 
whereas others have found QOL impairment to be more highly associated with the 
severity or number of compulsions (Moritz, et al., 2005). Study results have shown that 
the Y-BOCS compulsion subscale has no relationship to QoL impairment whereas the Y-
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BOCS obsession subscale contributes significantly to the relationship between QoL 
impairment in social and occupational functioning and OCD (Eisen, et al., 2006) . 
However, others have found that the number and severity of obsessions is most strongly 
related to the role-emotional and mental health subscales of QoL, whereas number of 
compulsions has a strong significant relationship with QoL across all domains (Moritz, et 
al., 2005). Often there is no relationship found between bodily pain (Fontenelle et al., 
2010; Moritz, et al., 2005), role-physical health and general health QoL and OCD even 
when other areas of QoL are highly associated (Moritz, et al., 2005). Obsessions and 
compulsions have also contributed equally to impairment in QoL (Huppert, et al., 2009). 
The role of obsessions versus compulsions on QoL in OCD is not fully established at this 
time. Symptom dimensions of OCD and their relationship with diminished QoL will be 
reviewed next. 
OCD symptom dimensions and QoL. Symptom dimensions in OCD may also 
be related to QoL.  Common symptoms of OCD that are related to diminished QoL in the 
OCD population as compared with other symptom dimensions include hoarding, 
ordering and washing symptoms. Hoarding may be defined as the collection and inability 
to get rid of items despite their apparent lack of value to others (Saxena et al., 2011). 
Ordering symptoms include obsessions about having items in a particular order and 
compulsive behavior to maintain the order of objects and prevent distress. Washing 
symptoms include obsessions related to contamination and cleanliness and compulsive 
washing/cleaning behaviors to prevent distress related to being contaminated (American 
Psychiatric Association, 2000). Persons with hoarding symptoms generally show a 
diminished QoL in the domains of safety/victimization, socialization and living situation 
(Fontenelle, et al., 2010; Huppert, et al., 2009; Saxena, et al., 2011). Persons with 
washing symptoms as compared to non-washers show more impairment in physical 
health QoL (Fontenelle, et al., 2010) and social functioning QoL (Huppert, et al., 2009). 
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Persons with ordering symptoms as compared with those with non-ordering symptoms 
may exhibit higher rates of impairment in social functioning QOL (Huppert, et al., 2009). 
 Importantly, studies addressing symptom dimensions often suggest that it is 
actually the presence of depressive and anxiety symptoms that account for the strength 
of the relationship between hoarding, ordering and washing symptom dimensions and 
QoL (Fontenelle, et al., 2010; Huppert, et al., 2009). After controlling for depression and 
anxiety symptoms, only the correlation between washing symptoms and social 
functioning, and ordering symptoms and work-related functioning remain significant 
(Huppert, et al., 2009). Contrarily, one study looking specifically at hoarding symptoms 
and QOL found that depressive and anxiety disorders did not moderate the relationship 
between the hoarding symptom dimension and diminished QoL. Rather, depressive and 
anxiety symptoms were equivalent across symptom dimension groups. (Saxena, et al., 
2011). The relationship between impaired QoL and OCD comorbidity is discussed next.  
Comorbidity. Comorbid affective and anxiety disorders contribute significantly to 
the diminished QoL experienced by those with OCD (Abramowitz, Storch, Keeley, & 
Cordell, 2007; Besiroglu, Uguz, Saglam, Agargun, & Cilli, 2007; Fontenelle, et al., 2010). 
However, the mechanism predicting the role of comorbidity on OCD QoL is unclear at 
this time. Comorbidity of OCD and MDD is related to a significantly diminished QoL and 
higher functional impairment as compared with individuals with non-comorbid OCD. 
Further, individuals with comorbid OCD-MDD and individuals with OCD alone have 
significantly worse QoL outcomes and greater functional impairment when compared to 
non-OCD controls. This is suggestive of the role of depression in accounting for the 
strength of the relationship between obsessions, compulsions and QoL (Huppert, et al., 
2009).  
The psychopathological processes mediated by OCD symptoms may predispose 
individuals to the development of depressive symptoms (Besiroglu, et al., 2007). 
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Specifically, individuals with comorbid OCD-MDD have significantly more severe 
obsessions and compulsions and are significantly more impaired in physical health, 
emotional well-being and social functioning QoL (Besiroglu, et al., 2007). Obsession 
severity, the presence of generalized anxiety disorder and aggressive obsessions are all 
associated with the development of MDD after OCD onset (Besiroglu, et al., 2007). 
Individuals with comorbid OCD-MDD tend to have more severe obsessions and 
compulsions, a greater tendency to misinterpret the significance of intrusive thoughts 
and poorer insight into symptoms. Functional impairment and the misinterpretation of 
intrusive thoughts are possible unique predictors of depression in individuals with OCD 
(Abramowitz, et al., 2007). The role of OCD symptom interference and resistance 
symptoms in QoL impairment are discussed next.  
Yale-Brown Obsessive-Compulsive Scale dimensions. Utilizing the 
dimensional structure of the Yale-Brown Obsessive-Compulsive Scale (Y-BOCS), it is 
possible to address OCD as a compilation of severity of obsessions, severity of 
compulsions, symptom interference, and resistance to symptoms (Moritz et al., 2002; 
Storch et al., 2005). Resistance symptoms as well as perceived control over symptoms 
has uniquely predicted functional impairment in adults with OCD (Storch, Abramowitz, & 
Keeley, 2009). Symptom interference, or the combination of severity of obsessions and 
compulsions, includes time occupied by obsessions/compulsions, interference of 
obsessions/compulsions with activities, and distress over obsessions/compulsions. 
Resistance symptoms includes ability to resist obsessions/compulsions and degree of 
perceived control over obsessions/compulsions. The role of symptom interference 
versus the role of resistance to symptoms has yet to be addressed as possible 
mediating variables in the relationship between OCD and QoL.  
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Present Study 
The present study seeks to expand the literature by clarifying the predictive 
components of diminished QoL in adults with OCD. First, this study will compare QoL in 
adults with OCD relative to historical controls of QoL in other psychiatric conditions, 
including major depressive disorder, panic disorder and schizophrenia. It is predicted 
that QoL in adults with OCD will be comparable to QoL in adults with major depressive 
disorder, panic disorder (Rapaport, et al., 2005) or schizophrenia (Bystritsky et al., 
2001). Second, this study will investigate the relationship between obsessive-compulsive 
symptom severity as well as obsessive-compulsive symptom dimensions with the four 
domains of QoL: physical health, emotional well-being, social functioning and general 
quality of life. It is predicted that obsessive-compulsive severity scores on the Y-BOCS 
will correlate inversely with QoL for emotional well-being, social functioning and general 
domains, yet will not be associated with physical health QoL (Eisen, et al., 2006; 
Masellis, et al., 2003; Moritz, et al., 2005; Rapaport, et al., 2005). It is expected that 
symptom dimensions of hoarding, washing and ordering measured by the Obsessive-
Compulsive Inventory Revised (OCI-R) will be associated with greater impairment in 
emotional well-being QoL, social functioning and general QoL as compared with other 
OCD symptom dimensions (Huppert, et al., 2009). It is possible that washing symptoms 
will be associated with diminished physical health QoL as the mere act of obsessive 
washing may impact role-physical functioning and bodily pain (Fontenelle, et al., 2010). 
This analysis will clarify the mixed results found in previously conducted research 
concerning the role of symptom severity and symptom dimensions on the relationship 
between OCD and diminished QoL. 
 Third, it is predicted that depression symptom severity on the BDI-II will 
moderate the relationship between OCD and QoL. This hypothesis will help expand on 
the literature that posits that depression plays a large role in moderating QoL in OCD by 
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differentiating whether the role of comorbid depressive symptoms (and their severity) or 
MDD diagnosis contributes to the relationship between OCD and QoL (Besiroglu, et al., 
2007; Huppert, et al., 2009). Similarly, this study will address the moderating role of 
OCD comorbidity with a compiled anxiety disorder variable (generalized anxiety 
disorder, posttraumatic stress disorder, agoraphobia, social phobia and panic disorder). 
It is predicted that anxiety disorder comorbidity will moderate the relationship between 
OCD and QoL because of the increased impairment related to the presence of two or 
more psychopathological conditions. Lastly, this study will investigate the mediating role 
of symptom interference on the Y-BOCS versus the mediating role of resistance 
symptoms on the Y-BOCS in the relationship between OCD and QoL impairment. This 
novel aim will illuminate the roles of these categorical symptom clusters on the 
relationship between OCD and QoL. 
Overall, past research addressing the relationship between OCD and QoL is 
limited. Comparisons of QoL in adults with OCD and other psychopathological conditions 
have yielded inconsistent findings. Studies examining the predictors of diminished QoL 
in OCD have shown that symptom severity and number of symptoms generally correlate 
with more impaired QoL. It is unclear at this time if this relationship is due to the number 
and severity of obsessive symptoms, compulsive symptoms or overall combined 
symptoms (Eisen, et al., 2006; Masellis, et al., 2003; Moritz, et al., 2005). Investigations 
of the role of symptom dimensions in the relationship between OCD and QoL have 
shown that persons with hoarding (Saxena, et al., 2011), washing and ordering 
symptoms have significantly more diminished QoL than adults with other symptom 
dimensions (Fontenelle, et al., 2010; Huppert, et al., 2009). Additionally, comorbidity of 
OCD and MDD has been shown to be significantly related to diminished QoL (Besiroglu, 
et al., 2007), yet it is unclear whether depression symptom severity or the presence of 
diagnosed MDD moderates this relationship. Lastly, the relationship between QoL and 
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the bidimensional components of resistance and interference on the Y-BOCS has yet to 
be investigated.  
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Method 
Participants 
Participants included 102 adults from an archival database with a principal 
diagnosis of OCD according to the Diagnostic and Statistical Manual of Mental Disorder 
– Fourth Edition – Text Revision (DSM-IV-TR; American Psychiatric Association, 2000) 
criteria. Participants were referred to a university based specialty clinic for cognitive-
behavioral treatment of OCD. Participants were given information about the study and 
presented with the option of taking part. Written consent was received by all persons 
choosing to participate in the study. Participants ranged in age from 18 to 79 years old 
(M = 29.4 ± 10.9 years) with 48% female (N = 49) and 52% male (N = 53). The ethnic 
distribution was Caucasian (96.3%), African American (1.9%), Asian (.9%), and other 
(.9%).  Unfortunately, further demographic information concerning socioeconomic class, 
education, and marital status was not available for these participants. 
Obsessive-compulsive disorder diagnoses as well as comorbid diagnoses were 
made by experienced clinical psychologists through an unstructured interview and 
verified with the Anxiety Disorder Interview Schedule- 4th edition (ADIS-IV) and the Y-
BOCS. Clinicians were trained by first observing five or more administrations of the 
ADIS-IV and the Y-BOCS and then administering the measures under direct supervision. 
Lifetime best estimate diagnoses were made with the unstructured interview, ADIS-IV 
and Y-BOCS (Leckman, Sholomskas, Thompson, Belanger, & Weissman, 1982). No 
rater integrity measures were used. Comorbid diagnoses among participants with OCD 
consisted of Panic Disorder (n = 15), Social Phobia (n = 32), Agoraphobia (n = 10), 
Generalized Anxiety Disorder (n = 39), Specific Phobia (n= 13), Post Traumatic Stress 
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Disorder (n = 1), Major Depressive Disorder (n = 37), Dysthymia (n = 14), Alcohol Abuse 
(n = 2), Substance Abuse (n = 1), Hypochondria (n = 1), and Psychotic Disorder Not 
Otherwise Specified (n = 4).   
Measures 
Anxiety Disorders Interview Schedule for DSM-IV (ADIS; Appendix A). The ADIS-
IV is a semi-structured clinical interview based on DSM-IV diagnostic criteria that 
assesses the presence of anxiety disorders and allows for functional analysis of the 
anxiety disorders. The ADIS-IV also provides sections that allow for the assessment of 
commonly comorbid disorders including mood, somatoform and substance use 
disorders. The ADIS-IV may be used to screen for psychotic symptoms and briefly 
addresses family psychiatric history. The ADIS-IV adheres to the multiaxial system of the 
DSM-IV and therefore is commonly used in research addressing anxiety and related 
disorders (Brown, DiNardo, & Barlow, 1994).  
Yale-Brown Obsessive Compulsive Scale (Y-BOCS; Appendix B). The Y-BOCS 
(Goodman et al., 1989 a; Goodman, Price, Rasmussen, & Mazure, 1989b) is a 10-item 
semi-structured clinician administered measure of obsession and compulsion severity. 
Each item addresses self-reported experiences in the last week. Questions are rated on 
a five-point Likert scale ranging from 0-4, with higher scores representing greater 
symptom severity. Items 1-10 (excluding items 1b and 6b) are used to determine a total 
severity score. Interference is defined as the sum of items one, two, three and six, 
seven, eight on the Y-BOCS (Goodman et al., 1989a; Goodman, Price, Rasmussen, & 
Mazure, 1989b). These items address time occupied by obsessions/compulsions, 
interference of obsessions/compulsions with activities, and distress over 
obsessions/compulsions. Resistance is defined as items four, five and nine, ten, which 
address efforts made to resist obsessions/compulsions and degree of perceived control 
over obsessions/compulsions (Goodman et al., 1989 a; Goodman, Price, Rasmussen, & 
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Mazure, 1989b).  Satisfactory psychometric properties for the Y-BOCS have been found, 
including internal consistency, convergent validity, and treatment sensitivity (Deacon & 
Abramowitz, 2005; Goodman et al., 1989a,b; Storch et al., 2004). The factor structure of 
the Y-BOCS, comprised of obsession and compulsion factors is psychometrically 
supported with satisfactory reliability and good convergent validity.  Divergent validity of 
the factor structure of the Y-BOCS is not entirely supported at this time (Deacon & 
Abramowitz, 2005; Storch, et al., 2005).  
Obsessive-Compulsive Inventory-Revised (OCI-R; Appendix C). The OCI-R is an 
18-item self-report measure that assesses the distress associated with obsessions and 
compulsions using six symptom dimension subscales which include: washing, checking, 
ordering, neutralizing, obsessing, and hoarding. Each subscale contains three-items that 
are rated on a five-point Likert scale measuring distress with values 0-4. Total scores for 
each symptom dimension may be determined by adding the three items for each 
individual subscale (Hunsley & Mash, 2008). Finding a total score on the OCI-R is 
misrepresentative of OCD severity as a person may have extremely high scores in one 
symptom dimension (e.g. hoarding) but very low scores in all other dimensions. It is 
therefore inaccurate to determine OCD severity based on an overall score as this score 
may not properly depict the severity of independent symptom dimensions.  For the 
purposes of this study, factor scores will be used. Good psychometric properties have 
been found for use of the OCI-R in anxious patients (Foa et al., 2002; Huppert et al., 
2006). The OCI-R is both highly sensitive and highly specific (Foa et al., 2002). 
Additionally, the OCI-R shows good convergent validity and performs well in 
discriminating OCD from other anxiety disorders (Abramowitz & Deacon, 2006).  
Beck Depression Inventory-Second Edition (BDI-II; Appendix D). Based on the 
original Beck Depression Inventory (Beck, Ward, Mendelson, Mock, & Erbaugh, 1961), 
the Beck Depression Inventory-Second Edition (BDI-II;  Beck, Steer, & Brown, 1996) is a 
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21-question, self-report inventory of depressive symptoms experienced during the past 
week.  Questions are rated on a four-point Likert scale ranging from 0-3, with higher 
scores representing greater symptom severity. A total score is calculated from the sum 
of all questions and is compared to a key to determine depression severity with a score 
of 0-9 indicating no depression, 10-18 mild to moderate depression, 19-29 moderate to 
severe depression and 30-63 indicating severe depression. Extensive reliability and 
validity data have been reported in clinical and non-clinical samples (Beck et al., 1996; 
Whisman, Perez, & Ramel, 2000). Psychometric analyses reveal that the second edition 
of the BDI is internally consistent and consists of two underlying factors addressing 1) 
cognitive-affective symptoms of depression and, 2) somatic symptoms of depression. 
Additionally, the high internal consistency supports the reliability of both the total score 
as well as the individual factor scores. The psychometric properties of the BDI-II support 
its use in evaluating the presence and severity of depressive symptomology (Whisman 
et al., 2000).  
 RAND MOS 36-Item Short Form Health Survey (Appendix E). The RAND MOS 
36-Item Short Form Health Survey (SF-36; Ware et al., 1993) consists of 36 items that 
assess domains of physical, emotional,  social and general quality of life. The scale is 
comprised of measures assessing eight different components of health including: 
physical functioning, physical role functioning, emotional role functioning, perceptions of 
general health, emotional health, energy/lethargy, bodily pain, and social functioning 
(Hays & Morales, 2001; Hays, Sherbourne, & Mazel, 1993). The SF-36 has shown good 
reliability and validity over diverse populations (McHorney, Ware, & Raczek, 1993; Ware 
et al., 1993). The three more specific domains assessed by the SF-36 have shown good 
psychometric properties with the physical health domain most accurately differentiating 
individuals on severity of chronic medical conditions, the emotional well-being domain 
most accurately distinguishing presence and severity of mental health disorders and the 
 
 
16 
 
social functioning domain covering both physical and mental health components 
(McHorney et al., 1993).  
Data Analysis 
In order to investigate the hypothesis concerning the comparability of QoL across 
conditions, one-sample t-tests were used to compare the eight different components of 
health including: physical functioning, physical role functioning, emotional role 
functioning, perceptions of general health, emotional health, energy/lethargy, bodily pain, 
and social functioning in OCD to historical means for QoL in panic disorder, major 
depressive disorder and schizophrenia. Historical data from adults with panic disorder 
was taken from a study addressing QoL scores on the MOS-36 (N = 62) (Simon et al., 
2002). Data from adults with major depressive disorder was taken from a study 
addressing QoL on the MOS-36 (N = 54) (Schonfeld et al., 1997). Lastly data from adults 
with schizophrenia (N = 137) was taken from Sciolla, Patterson, Wetherell, McAdams, 
and Jeste (2003) looking at QoL on the MOS-36. Correlations were used to investigate 
the hypothesis that symptom severity on the Y-BOCS is inversely related to QoL scores 
on the MOS-36. Correlation matrices were then used to examine the hypothesis that 
hoarding, washing and ordering symptoms on the OCI-R were more significantly related 
to diminished QoL scores than other symptom dimensions on the OCI-R. For all 
analyses a p value of less than 0.05 was used for significance testing. 
An a priori power analysis was conducted to determine the needed strength of 
interactions to show significant effects. Hierarchical linear regression analyses were 
again used to assess the unique contribution of depression severity scores on the BDI-II 
in predicting MOS-36 QoL scores after accounting for the variance explained by the Y-
BOCS severity score. In each analysis, the Y-BOCS severity score was entered in step 
one, BDI-II severity score in step two, and the interaction of Y-BOCS severity scores and 
BDI-II severity scores in step three. Similarly, hierarchical linear regression analyses 
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were used to assess the unique contribution of the presence of psychiatric diagnoses of 
major depressive disorder and, separately, the presence of any anxiety disorder on 
MOS-36 QoL total score after accounting for the variance explained by the Y-BOCS 
severity score. Anxiety disorder was a grouped and dummy coded variable combining 
DSM-IV diagnoses of generalized anxiety disorder, posttraumatic stress disorder, 
agoraphobia, social phobia and panic disorder. In the first of the two analyses, the Y-
BOCS severity score was entered in step one, presence of major depressive disorder in 
step two, and the interaction of Y-BOCS severity scores and the presence of major 
depressive disorder in step three. In the second of the two analyses, the Y-BOCS 
severity score was entered in step one, presence of dummy coded anxiety disorder in 
step two, and the interaction of Y-BOCS severity scores and the presence of dummy 
coded anxiety disorder in step three.  
Mediational analyses addressed whether symptom interference or resistance 
symptoms mediated the relationship between OCD and QoL across the four domains of 
physical health, emotional well-being, social functioning and general QoL. Using the 
bootstrapping mediation method, the provided sample was resampled k=5,000 times 
generating a 95% confidence interval. The criterion for mediation was the exclusion of 
zero between the lower and upper bound of the confidence interval. If zero was not 
present it indicated that the indirect effect of the mediator on the outcome was not zero 
with 95% confidence (Hayes, 2009). 
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Results 
Sample Characteristics 
 Means and standard deviations for various study measures are presented in 
Table 1. Zero-order correlations highlighted a significant negative relationship between 
age and both emotional (r = -0.34) and social functioning (r = -0.35) QoL. Independent 
group t-tests indicated a significant gender difference on emotional health QoL (t(100) = 
-2.07, p < 0.05) with females experiencing significantly more diminished emotional health 
QoL than males. No further differences were noted on any other domain of QoL, Y-
BOCS total score or OCI-R total score for age, gender or ethnicity.  
One sample t-tests were used to compare scores on the eight components of 
QoL on the MOS-36 (physical functioning, physical role functioning, emotional role 
functioning, perceptions of general health, mental health, energy/lethargy, bodily pain, 
and social functioning) in persons with OCD relative to historical means for QoL in 
persons with panic disorder, major depressive disorder (MDD) and schizophrenia as 
represented in Table 2. Social functioning QoL was significantly worse and physical 
health QoL (including role-physical, physical functioning and bodily pain) was 
significantly better in those with OCD as compared to patients with schizophrenia, panic 
disorder or MDD. Additionally, role emotional QoL and vitality/energy was worse for 
those with OCD relative to those with either schizophrenia or panic disorder. Persons 
with OCD had significantly worse general health than those with panic disorder, but 
significantly better general health than those with MDD. Mental health did not differ 
across OCD, panic disorder and MDD; persons with schizophrenia fared better in this 
domain.  
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Associations Between QoL, Symptom Severity and Symptom Dimensions  
As predicted, symptom severity on both the Y-BOCS and the CGI-Severity was 
negatively correlated with emotional health (r = -.24, p < 0.05), social functioning (r = -
0.32, p < 0.01) and general health (r = -0.30, p < 0.01) QoL domains (Table 3). There 
was no significant relationship between obsessive-compulsive symptom severity and 
physical health QoL. With respect to the OCI-R subscales and QoL domains, only 
hoarding was negatively correlated with general health QoL (r = -0.24, p < 0.05), and 
neutralizing was positively correlated with both emotional health (r = 0.36, p < .01) and 
social functioning (r = 0.21, p < 0.05) QoL (Table 4).   
OCD Comorbidity 
Table 5 displays the t- and significance values for independent t- tests comparing 
the OCD only and comorbid OCD groups across study variables. Comorbidity with OCD 
was related to increased OCD symptom severity as indicated by both the Y-BOCS total 
score and the CGI-Severity, higher endorsement of interference of and distress from 
obsessive-compulsive symptoms, and significantly more diminished emotional health, 
social functioning and general health QoL when compared to an OCD only group.  
Moderation Analyses 
An a priori power analysis utilizing a power of 0.80 and an alpha of 0.05 revealed 
an effect size of 0.07 indicating that interactions would need to account for 7% of the 
variance in order for an interaction to be significant. Three moderation analyses were 
conducted to examine the role of depressive symptom severity as indicated by the BDI-
II, major depressive disorder diagnosis and anxiety diagnosis in the relationship between 
obsessive-compulsive symptom severity and QoL. When looking at depressive symptom 
severity, step 1 of the hierarchical regression revealed obsessive-compulsive symptom 
severity to be a predictor of diminished QoL across all domains excluding physical health 
(emotional health QoL, β = -0.21, R2 = 0.04, p < 0.05; social functioning QoL, β = -0.32, 
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R2 = 0.11, p < 0.01; general health QoL, β = -0.28, R2 = 0.08, p < 0.01). Step 2 indicated 
that depressive symptom severity predicted diminished QoL across all domains above 
and beyond obsessive-compulsive symptom severity (physical health, β = -0.24, R2 = 
0.06, p < 0.05; emotional health QoL, β = -0.68, R2 = 0.44, p < 0.001; social functioning 
QoL, β = -0.47, R2 = 0.30, p < 0.001; general health QoL, β = -0.53, R2 = 0.31, p < 
0.001). Step 3 revealed a non-significant interaction between obsessive-compulsive 
symptom severity and depressive symptom severity.  
When utilizing a diagnosis of MDD as a moderating variable, step 1 indicated a 
significant relationship between obsessive-compulsive symptom severity and QoL. Step 
2 indicated that an MDD diagnosis was related to diminished QoL across all domains, 
excluding physical health, above and beyond obsessive-compulsive symptom severity 
(emotional health QoL, β = -0.46, R2 = 0.25, p < 0.001; social functioning QoL, β = -0.49, 
R2 = 0.32, p < 0.001; general health QoL, β = -0.32, R2 = 0.18, p < 0.01). Step 3 
revealed a non-significant interaction between obsessive-compulsive symptom severity 
and depression diagnosis.  
Lastly, an anxiety disorder variable was examined as a possible moderating 
variable. Step 1 again indicated the predictive role of obsessive-compulsive symptom 
severity on diminished QoL. However, both steps 2 and 3 were non-significant indicating 
that comorbid anxiety does not affect QoL in a meaningful way. This set of analyses 
revealed that the relationship between obsessive-compulsive symptom severity and 
diminished QoL is not moderated by comorbid depression or anxiety. However, it is 
interesting to note the significant predictive role of depression in diminished QoL. Had 
significant moderators been revealed, a simple slope analysis would have been 
conducted to further explore these interactions.  
 
 
 
 
21 
 
Mediational Analyses 
The Y-BOCS was examined to investigate the possible mediating roles of 
interference of obsessive-compulsive symptoms and/or resistance to obsessive-
compulsive symptoms on QoL. In order to investigate this aim, first a moderational 
analysis was run to determine the significance of the interaction between interference of 
symptoms and resistance to symptoms. In this analysis, the dependent variable was 
CGI-Severity, interference of symptoms was entered into step 1, resistance to symptoms 
in step two and the interaction of interference and resistance in step 3.  No significant 
interaction was noted for interference of obsessive-compulsive symptoms and resistance 
to obsessive-compulsive symptoms (t (3) = 1.04, p = 0.30). In order to ensure that the 
CGI-Severity appropriately reflected obsessive-compulsive symptom severity and was a 
reasonable independent variable for the subsequent mediational analyses, a correlation 
was run between the Y-BOCS and the CGI-Severity, showing a statistically significant 
correlation between the two measures (r = .663, p < 0.001). Next, two sets of four 
bootstrapping mediational analyses were run with k = 5,000, generating 95% confidence 
intervals to estimate the indirect path (Table 6).  
Interference of obsessive-compulsive symptoms as a mediator. In the first 
set of four analyses, the independent variable was CGI-Severity, the mediating variable 
was Y-BOCS interference of obsessive-compulsive symptoms and the dependent 
variable was MOS QoL domain (physical health, emotional health, social functioning, 
general health). Bootstrapping confidence intervals revealed that interference of 
obsessive-compulsive symptoms mediated the relationship between CGI-Severity and 
emotional health (-11.79; 95% CI -21.24 to -1.79), social functioning (-9.10; 95% CI -
13.50 to -5.18) and general health (-9.04; 95% CI -14.99 to -2.89) QoL but not physical 
health QoL (-1.88; 95% CI -17.65 to 11.37). These findings suggest that the interference 
of obsessive-compulsive symptoms in daily living, as well as the distress related to these 
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symptoms accounts for the relationship between obsessive-compulsive symptom 
severity and diminished QoL across three domains.  
Resistance to obsessive-compulsive symptoms as a mediator. In the 
second set of four analyses, the independent variable was CGI-Severity, the mediating 
variable was Y-BOCS resistance to symptoms and the dependent variable was MOS 
QoL domain. Bootstrapping confidence intervals revealed that resistance to obsessive-
compulsive symptoms only mediated the relationship between obsessive-compulsive 
symptoms and social functioning QoL (2.16; 95% CI 0.35 to 5.25). Resistance to 
obsessive-compulsive symptoms was a nonsignificant mediator of physical health (3.27; 
95% CI -0.97 to 11.48), emotional health (1.77; 95% CI -1.53 to 6.97) and general health 
QoL (-0.12; 95% CI -2.73 to 2.67).  
Further investigation into the mediating factors for social functioning QoL. 
Due to the mediating role of both interference of and resistance to obsessive-compulsive 
symptoms on social functioning QoL, a third set of analyses was run to further 
investigate this outcome (Table 7). In this analysis, both interference and resistance 
were entered at the same time as mediating variables, with CGI-Severity as the 
independent variable and social functioning QoL as the dependent variable. Both 
interference of symptoms (-11.00; 95% CI -15.72 to -7.02) and resistance to symptoms 
(3.16; 95% CI 1.09 to 6.85) retained their significance when evaluated at the same time. 
Lastly, because of the original role of these variables as dimensions of the Y-BOCS, a 
bootstrapping mediation analysis was run looking at Y-BOCS total score as the 
mediator, CGI-Severity as the independent variable and social functioning QoL as the 
dependent variable. Y-BOCS total score was not a significant mediator of the 
relationship between obsessive-compulsive severity and social functioning QoL (-2.57; 
95% CI -7.02 to 2.12). 
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Discussion 
The current study reported on various contributing factors to diminished QoL in 
adults with OCD. Associations between obsessive-compulsive symptom severity, 
obsessive-compulsive symptom dimensions, comorbidity and symptom clusters were 
explored. Consistent with previous research, obsessive-compulsive symptom severity 
was positively correlated with diminished emotional health, social functioning and 
general health QoL, but not physical health QoL (Eisen et al., 2006; Masellis, Rector, & 
Richter, 2003; Moritz et al., 2005). A comparison of QoL across four psychiatric 
conditions including OCD, MDD, panic disorder and schizophrenia revealed many group 
differences. Interestingly, persons with OCD had significantly worse social functioning 
QoL than persons with any of the three other disorders explored. This finding highlights 
the conspicuous and social nature of OCD. Social functioning is deeply impacted by the 
time, interference and distress related to intrusive obsessions and reflexive compulsions 
(Markarian, et al., 2010; Storch et al., 2006). Additionally, symptoms may be time 
consuming and interfere with employment/academic success as well as time spent with 
family or friends, thereby limiting a person’s opportunities to experience functional and 
positive social interactions(Yaryura-Tobias et al., 2000). This decrease in routine social 
interactions may be associated with the decrease in social functioning QoL in those with 
OCD. 
 In addition to the decrease in social functioning QoL, those with OCD had 
significantly more diminished role emotional health and vitality/energy QoL as compared 
to those with panic disorder or schizophrenia and significantly worse mental health QoL 
relative to those with schizophrenia. It is possible that those with schizophrenia do not 
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have as clear insight into their emotional well-being and mental health, which may be 
reflected in this finding (i.e., those with OCD recognize the extent of their illness and 
impairment in a different way from someone with schizophrenia). However, a person’s 
insight into their OCD, as well as symptom chronicity (Rasmussen & Eisen, 1994) may 
contribute to this detriment in emotional health and vitality/energy QoL. Additionally, 
those with OCD had significantly worse general health QoL than those with panic 
disorder, again indicating the severity of obsessive-compulsive symptoms and their 
impact on daily functioning. This finding reflects on the lack of general well-being felt by 
those with a chronic disease such as OCD. Unfortunately, obsessive-compulsive 
symptoms may interfere with activities of daily living and may limit contact with friends 
and family members (Bobes, et al., 2001). Functional and social impairment, in addition 
to the possibility of comorbid depression and other anxiety disorders may impact feelings 
of overall well-being, thereby diminishing general health QoL (Abramowitz, et al., 2007; 
Huppert, et al., 2009). Contrastingly, comparisons across disorders revealed that 
persons with OCD fared better in general health QoL than did those with MDD and had 
better physical health QoL than persons with MDD, panic disorder or schizophrenia. This 
finding is consistent with others that have shown that physical health QoL is not 
generally impacted by OCD (Hollander, 2010; Rapaport, et al., 2005).  
Significant negative correlations between age and both emotional health and 
social functioning QoL were found.  The negative relationship between age and social 
functioning QoL may be explained by the possible withdrawal from interpersonal 
relationships experienced by older adults with OCD in attempts to cope with their 
symptoms. The negative correlation between age and emotional health QoL may be 
explained by helplessness and hopelessness related to sustained illness. More 
specifically, persons of older age may have a greater understanding of the chronicity of 
their illness and may thereby have a better recognition of their level of impairment. After 
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years of being ill, one might feel that they have exhausted all options for reducing 
symptoms and may feel that the disorder is interminable. It is also possible that those 
who become symptomatic at a later age have an awareness of how significantly their 
QoL has declined; those who develop the disorder earlier may not have as strong a 
basis for comparison.  Regarding gender, being female was negatively related to 
emotional health QoL, but not social functioning, general health or physical health QoL. 
It is possible that gender differences in comorbidity or depressive symptomology (e.g., 
self-worth, anhedonia) may contribute to the relationship between gender and emotional 
health QoL, as aversive feelings may be related to more negative emotionality (Huppert, 
et al., 2009; Rapaport, et al., 2005). Additionally, women may perceive significant role 
strain, which may increase negative feelings thereby decreasing emotional health QoL 
(Camporese, Freguja, & Sabbadini, 1998) 
Obsessive-compulsive symptom severity, depression symptom severity and the 
presence of comorbid MDD were associated with a decline in functioning. Anxiety 
disorder comorbidity was not related to a decline in functioning, suggesting that 
comorbid anxiety disorders do not affect QoL in adults with OCD (Barrera & Norton, 
2009). The main effects of obsessive-compulsive symptom severity and depression 
symptom severity draw evidence to the unique contribution of each symptom domain on 
QoL, with depression exerting effects over and above obsessive-compulsive severity on 
QoL outcomes. No interactions were found between obsessive-compulsive severity and 
the depression or anxiety disorder variables in predicting a decline in functioning in those 
with OCD. Nonsignificant interactions indicate that the strengths of the relationships 
between two disorders do not outweigh the significance of the main effects for each 
disorder. However, consistent with others (Cassin, Richter, Zhang, & Rector, 2009; 
Fontenelle, et al., 2010; Huppert, et al., 2009), group comparisons between those with 
comorbid OCD (anxiety or depressive disorders) and those with OCD only revealed that 
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those with comorbid conditions  had significantly more diminished emotional health, 
social functioning and general health QoL. These results reflect a general pathology 
model indicating that the addition of a comorbid condition plays a role in the severity of 
obsessive-compulsive symptoms and decreased QoL (Schonfeld, et al., 1997).  The 
combination of having more than one disorder is associated with more impaired 
functioning, higher rates of generalized anxiety and significantly more debilitating 
obsessions and compulsions (Abramowitz, et al., 2007; Cassin, et al., 2009).  
Unique to this study was the exploration of the mediating role of obsessive-
compulsive symptom interference and resistance. Interference of obsessive-compulsive 
symptoms mediated the relationship between obsessive-compulsive severity and 
diminished emotional health, social functioning and general health QoL. The degree of 
interference of symptoms directly impacted the diminished QoL experienced by adults 
with OCD suggesting that interference of obsessive-compulsive symptoms is the 
underlying mechanism explaining the relationship between obsessive-compulsive 
severity and diminished emotional health, social functioning and general health QoL. 
Interference of symptoms may reduce engagement in routine (e.g. going to work) or 
pleasurable (e.g. seeing friends) activities, as activities are interrupted and time is 
occupied by obsessive-compulsive symptoms. A higher degree of distress related to 
these symptoms may also prevent time spent in more productive activities. The inability 
to participate in multiple aspects of daily functioning, including maintaining employment 
or academic success impedes on chronic illness coping and decreases QoL across 
multiple domains.  
Resistance to obsessive-compulsive symptoms (i.e., effort to resist symptoms 
and perceived degree of control over symptoms) mediated the relationship between 
obsessive-compulsive symptom severity and social functioning QoL. However, further 
investigation into the unique role of each mediator revealed that interference of 
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symptoms and resistance to symptoms mediated the relationship between obsessive-
compulsive severity and social functioning QoL in opposite ways. Specifically, 
interference of symptoms (i.e., time spent on symptoms, distress over symptoms, and 
interference of symptoms in daily activities) was related to diminished social functioning 
QoL, whereas resistance to symptoms (i.e., effort to resist symptoms and perceived 
degree of control over symptoms) was related to increased social functioning QoL. 
Resistance to obsessive-compulsive symptoms may serve as a protective factor in 
maintaining healthy social functioning. The ability to resist symptoms may allow for more 
participation in social or occupational activities which may be associated with increased 
social functioning QoL. When little effort is made to resist symptoms, engagement in 
daily activities may be lessened and functional disability greater (Storch, et al., 2009). 
Ultimately, when utilizing the Y-BOCS total score as a single mediator in social 
functioning, it was non-significant further highlighting the unique role of the bi-
dimensional structure of this measure in explaining the mediational relationship. It is 
suspected that this non-significant result is due to the positive and negative mediational 
effects of the two dimensions canceling each other out.  
Obsessive-compulsive symptom dimensions did not play a significant role in the 
relationship between OCD and QoL with only hoarding negatively related to general 
health QoL, and neutralizing positively related to emotional health and social functioning 
QoL. It is interesting to note the possibility that neutralizing symptoms may be modestly 
‘protective’ of both emotional health and social functioning QoL; this finding may indicate 
that neutralizing behaviors diminish resulting distress thereby increasing QoL.  However, 
despite being protective of QoL, neutralizing symptoms are problematic as they feed into 
the obsessive-compulsive cycle of responding to excessive ruminations with anxiety-
reducing behaviors, subsequently further perpetuating illness (Salkovskis, Thorpe, Wahl, 
Wroe, & Forrester, 2003). Ultimately, nearly null findings regarding symptom dimensions 
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highlight the fact that OCD is unilaterally related to diminished QoL despite the specific 
symptom presentation. Across dimensions, persons with OCD seem to have a largely 
impacted QoL within multiple domains.  
Limitations and Implications 
This study has several limitations worth noting. First, the study did not have the 
high power needed to detect moderational effects (McClelland & Judd, 1993). Having a 
larger sample may help clarify if non-significant interaction effects are a function of 
power or lack of presence, and elucidate why comorbid OCD versus OCD alone showed 
mean differences at the group level. Second, the demographic homogeneity of the 
sample limits its generalizability to a more diverse population. On balance, the sample 
was well divided between genders and covered a wide range of ages. Unfortunately, 
many demographic variables were not reportable as the data was taken from an archival 
database and were not available. Third, these results do not imply causality and should 
not be interpreted as such. Most notably, although it is assumed that OCD 
symptomology leads to decreased QoL, it may be that individuals with lower QoL are at 
a greater risk for the development of OCD. Despite this, mediational effects do show a 
direct pathway between variables and may be reflective of a causative agent in the 
relationship between obsessive-compulsive symptom severity and QoL (Hayes, 2009). 
Future research may attempt to investigate quality of life longitudinally in order to 
properly display the causative effects of OCD symptoms and severity on QoL. A 
prospective study of QoL would benefit from identifying persons prior to symptom 
expression or early in the disease course.  
In lieu of these limitations, this study sheds light onto the contributing factors 
associated with diminished QoL in adults with OCD. Several past findings were 
replicated, validating their consistency over time and within various samples. Ultimately, 
this study points to the fact that QoL is important in gaining a complete understanding 
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into the complex picture of OCD. This research is consistent with the idea that the 
severity of symptoms (specifically interference of symptoms), rather than the symptom 
dimension, is highly related to QoL impairment.  
This study has important clinical and scientific implications since QoL is 
significantly reduced in adults with OCD as compared to those without psychopathology. 
Most measures and treatments for OCD focus on symptom reduction, however, it is 
important to address the diminished QoL related to the presence of OCD. Without 
addressing QoL, clinicians may not be addressing individual’s perceived impairment and 
the daily interference of OCD with areas of physical, emotional, social and general 
functioning. Understanding the roles of the factors that contribute to diminished QoL in 
adults with OCD will help guide clinicians to focus on the aspects of OCD that will yield 
the greatest improvement across QoL domains.  This study also sheds light on the other 
supports needed to improve QoL in OCD such as symptom reduction, treatments for 
comorbid conditions, and social supports. For example, treatments may begin with the 
preliminary aim of reducing symptoms and follow symptom reduction with life and social 
skills training to address areas of diminished QoL. Clarity concerning the specific 
features of OCD that contribute to diminished QoL will help researchers target future 
investigations and ultimately allow for greater specificity in the development of 
treatments aimed at improving QoL in adults with OCD.  
 It is essential to consider the role of QoL when working clinically with persons 
with OCD.  In order to gain complete clinical remission, not only do obsessive-
compulsive symptoms need to be eradicated, but QoL needs to be targeted for 
improvement. Psychopharmacological therapy with various SRIs and psychotherapeutic 
treatments utilizing CBT are widely used for the treatment of OCD (Abramowitz, 2006; 
Foa, 2010). Attenuation of obsessive-compulsive symptoms with these treatments is 
often directly related to improvements in varying domains of QoL (Diefenbach, 
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Abramowitz, Norberg, & Tolin, 2007; Hollander, 2010; Koran et al., 2010; Tenney, 
Denys, van Megen, Glas, & Westenberg, 2003). However, despite the efficacy of both 
psychopharmacology and CBT attenuating obsessive-compulsive symptoms and 
improving QoL, there is more work that needs to be done to attain a more complete QoL. 
Treatments specifically aimed at improving daily functioning for the long-term must be 
incorporated into psychotherapy with the goal of significantly enhancing QoL (Bystritsky, 
et al., 2001). A two-tiered approach, outlined by Bystritsky et al. (2001) suggests that 
initial treatments must aim to reduce obsessive-compulsive symptoms as they impede 
QoL and hinder the person’s ability to excel in psychosocial functioning. Subsequently, 
this treatment must be followed by psychosocial rehabilitation which strives to increase 
QoL by improving social functioning, enhancing coping techniques and aiding with 
practical goals such as finding appropriate employment.  
The mediating role of interference of symptoms and resistance to symptoms 
helps better our understanding of what exactly impacts QoL in persons with OCD. In 
addition to including psychosocial rehabilitation, psychotherapeutic practice for the 
treatment of OCD must carefully incorporate CBT techniques (including 
psychoeducation, cognitive restructuring and exposure and response prevention) that 
target the reduction of interference and increase efforts to resist symptoms. Knowing 
that resistance to symptoms plays a protective role in social functioning QoL is important 
to clinical practice; CBT can be tailored to improve social functioning QoL by 
incorporating homeworks involving increased social interactions. Motivational 
interviewing may be useful in enhancing exposure and response prevention techniques 
by encouraging resistance to symptoms during anxiety-provoking situations (Simpson, 
Huppert, Petkova, Foa, & Liebowitz, 2006; Storch, et al., 2009).  Ultimately, treatment for 
OCD must focus on both symptom reduction through the use of psychotherapeutic 
techniques and/or psychopharmacology (in severe cases; Foa, 2010) and on the 
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improvement of QoL and daily functioning through psychosocial rehabilitation and the 
maintenance of symptom attenuation or eradication.  
Overall, this study shed new light on the mediating role of interference of and 
resistance to symptoms in the QoL of persons with OCD. This study highlights the 
necessity of including techniques in clinical practice that aim to both reduce OCD 
symptoms and improve QoL. Ultimately, the attenuation of problematic functioning in 
OCD is related to both the interference of OCD symptoms and the association of these 
symptoms to diminished QoL.  
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Appendix 1 
Tables 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 1. Means (standard deviations) on study variables 
Variable 
M (SD) for 
this study 
M (SD) from other OCD 
Studies 
Y-BOCS Total 27.90 (5.50) 24.52 (5.50)a 
Score 
  
          Interference 16.91 (3.89) 14.48 (4.17)a 
          Resistance 10.99 (2.63) 10.03 (2.94)a 
OCI-R Total 23.95 (11.73) 27.02 (13.22)b 
Score 
  
          Washing 4.08 (4.25) 5.04 (4.32)b 
          Checking 4.51 (4.15) 4.98 (3.74)b 
          Obsessing 6.37 (3.54) 6.40 (4.05)b 
          Neutralizing 2.47 (3.27) 2.62 (3.42)b 
          Ordering 4.21 (3.78) 4.88 (4.04)b 
          Hoarding 2.17 (2.83) 3.19 (3.70)b 
BDI-II 16.84 (10.44) 17.11 (10.35)a 
Note: Y-BOCS, Yale-Brown Obsessive-Compulsive Scale; OCI-R, 
Obsessive-Compulsive Inventory-Revised; BDI-II, Beck 
Depression Inventory-II; OCD, Obsessive-compulsive disorder. 
a Storch et al. 
(2009) 
  b Abramowitz and Deacon, (2006) 
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         Table 2. Quality of life means (MOS-36) across conditions  
   Group/effect MOS-36 Quality of Life Domains 
  
Physical 
Functioning 
Role-
Physical 
Role-
Emotional 
Vitality/ 
Energy 
Mental 
Health 
Social 
Functioning 
Bodily 
Pain 
General 
Health 
Reference 
Group:      OCD 
(N = 102) 88.43 77.21 33.33 38.77 47.1 48.41 82.6 64.46 
Schizophrenia                
(N = 137) 65.0** 54.44** 62.5** 54.8** 66.1** 68.7** 68.9** 62.8 
Panic disorder                 
(N = 62) 79.6** 54.9** 55.5** 51.5** 47.7 61.0** 68.1** 71.1* 
MDD (N = 54) 82.5* 55.6** 37.4 35.5 48.6 60.3** 61.6** 54.9** 
Note: One sample t-tests co mpare current OCD reference group with other diagnostic groups.                                                                    
**p<.001, *p<.05 
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     Table 3. Correlations of OCD symptom severity and quality of life domains (MOS-36) 
Group/effect Mos-36 Quality of Life Domains 
  Physical Emotional Social General 
Y-BOCS Severity -0.07 -0.24* -0.32** -0.30* 
CGI- Severity -0.17 -0.25* -0.37** -0.25* 
**p<.001, *p<.05 
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     Table 4. Correlations of OCD symptom dimensions (OCI-R) and quality of life domains (MOS-36) 
Group/effect                         Quality of Life Domains 
  Physical Emotional Social General 
Washing -0.02 0.03 -0.11 -0.05 
Obsessing -0.09 -0.17 -0.05 -0.12 
Hoarding -0.11 -0.05 -0.19 -0.26* 
Ordering 0.14 0.14 0.01 0.00 
Checking 0.06 0.17 -0.04 -0.16 
Neutralizing 0.03 0.36** 0.21* 0.05 
**p<.001, *p<.05 
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    Table 5. "Pure" OCD (No Comorbidity) (N = 28) Versus Comorbidity (N = 71) 
Variable 
"Pure" OCD 
Means (SD)  
Comorbid Means 
(SD)  
t-value 
Y-BOCS Total 25.56 (6.22) 28.78 (4.97) 2.76* 
Y-BOCS Interference 15.04 (4.13) 17.62 (3.57) 3.13* 
Y-BOCS Resistance 10.52 (2.85) 11.16 (2.54) 1.15 
CGI-Severity 4.64 (0.91) 5.31 (0.86) 3.59* 
MOS- Physical Health 266.96 (53.24) 241.15 (72.21) -1.62 
MOS- Emotional Health 103.71 (56.24) 71.62 (47.30) -3.00* 
MOS- Social Functioning 60.71 (24.93) 43.75 (26.11) -3.02* 
MOS- General Health 122.32 (30.84) 96.01 (31.88) -3.88** 
*p< 0.01, **p<0.001 
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Table 6. Mediators in the relationship between illness severity and QoL. Data include coefficient(SE). 
Mediators entered independently a path b path c path c' path 
Indirect 
effects 
(coefficient) 
95% CI 
Interference of Symptoms 
      
               Physical Health QoL 
2.95(0.30)** -0.64(2.43) -12.44(7.32) 
-
10.56(10.28) -1.88 -17.65 to 11.37 
               Emotional Health QoL 2.95(0.30)** -3.99(1.76)* -14.03(5.43)* -2.25(7.45) -11.79 -21.24 to 1.79* 
               Social Functioning QoL 
2.95(0.30)** 
-
3.08(0.84)** 
-
10.89(2.70)** -1.79(3.56) -9.10 -13.50 to -5.18* 
               General Health QoL 2.95(0.30)** -3.06(1.14)* -9.05(3.54)* -0.01(4.80) -9.04 -15.00 to -2.89* 
Resistance to Symptoms 
                     Physical Health QoL 1.01(0.27)** 3.22(2.73) -12.44(7.32) -15.71(7.82)* 3.27 -0.97 to 11.48 
               Emotional Health QoL 1.01(0.27)** 1.74(2.04) -14.03(5.43)* -15.80(5.83)* 1.77 -1.53 to 6.97 
               Social Functioning QoL 1.01(0.27)** 2.13(0.99)* 
-
10.89(2.70)** 
-
13.05(2.84)** 2.16 0.35 to 5.25* 
               General Health QoL 1.01(0.27)** -0.12(1.33) -9.05(3.54)* -8.93(3.81)* -0.12 -2.73 to 2.67 
*p<0.05 p<0.001   
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Table 7. Further evaluation of mediation for social functioning QoL. Data include coefficient(SE) unless otherwise specified. 
Mediators entered together a path b path c path c' path 
Indirect 
effects 
(coefficient) 
95% CI 
Interference of Symptoms 2.95(.30)** -3.72(.83)** -10.89(2.70)** -3.05(3.41) -11.00 -15.72 to -7.02* 
Resistance to Symptoms 1.01(.27)** 3.12(.93)* -10.89(2.70)** -3.05(3.41) 3.16 1.09 to 6.85* 
Total ------ ------ ------ ------ -7.84  -12.60 to -3.81* 
*p<0.05  **p< 0.001 
       
